STOCK TITAN

[6-K] Eason Technology Ltd Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Eason Technology Limited reported it received a NYSE American notice of noncompliance with continued listing standards. The exchange cited stockholders’ equity of RMB 28 million (approximately USD$3.8 million) as of December 31, 2024, and losses from continuing operations and/or net losses in three of the four most recent fiscal years.

The company must submit a compliance plan by November 13, 2025, and regain compliance by April 14, 2027, under Section 1009 procedures. If a plan is not submitted or accepted, or if progress and compliance are not achieved by the deadline, delisting proceedings may commence, with appeal rights under Section 1010 and Part 12. The notice has no immediate impact on the listing of the company’s ADSs, which will continue to trade during the cure period subject to other NYSE American requirements.

Eason Technology Limited ha ricevuto una notifica NYSE American di non conformità ai requisiti di quotazione continuata. Lo scambio ha citato come patrimonio netto di RMB 28 milioni (circa 3,8 milioni di USD) al 31 dicembre 2024, e perdite dalle operazioni continue e/o perdite nette in tre dei quattro ultimi esercizi fiscali.

La società deve presentare un piano di conformità entro il 13 novembre 2025 e ripristinare la conformità entro il 14 aprile 2027, ai sensi delle procedure della Sezione 1009. Se un piano non viene presentato o accettato, o se i progressi e la conformità non sono raggiunti entro la scadenza, possono avviarsi le procedure di ritiro dalla quotazione, con diritti di ricorso ai sensi della Sezione 1010 e della Parte 12. La notifica non ha alcun impatto immediato sulla quotazione degli ADS dell'azienda, che continueranno a negoziarsi durante il periodo di conformità soggetti ad altri requisiti NYSE American.

Eason Technology Limited informó que recibió una notificación de NYSE American por incumplimiento de los estándares de listado continuado. La bolsa citó un patrimonio de los accionistas de RMB 28 millones (aproximadamente USD 3,8 millones) al 31 de diciembre de 2024, y pérdidas de operaciones continuas y/o pérdidas netas en tres de los cuatro años fiscales más recientes.

La empresa debe presentar un plan de cumplimiento antes del 13 de noviembre de 2025 y restablecer el cumplimiento antes del 14 de abril de 2027, conforme a los procedimientos de la Sección 1009. Si no se presenta o no se acepta un plan, o si no se logran avances y cumplimiento antes de la fecha límite, pueden iniciarse procedimientos de retirada de la cotización, con derechos de apelación bajo la Sección 1010 y la Parte 12. La notificación no tiene un impacto inmediato en la cotización de las ADS de la empresa, que seguirán negociándose durante el periodo de cure, sujeto a otros requisitos de NYSE American.

Eason Technology Limited는 NYSE American의 상장 유지 기준 비준수 통지를 받았다고 발표했다. 거래소는 2024년 12월 31일 기준 주주지분이 2,800만 Renminbi(RMB)이고(약 380만 달러) 그리고 최근 4개 회계연도 중 3개에서 계속영업으로 인한 손실 및/또는 순손실이 발생했다고 밝혔다.

회사는 2025년 11월 13일까지 준수 계획을 제출하고 2027년 4월 14일까지 준수를 회복해야 하며, 이는 제1009조 절차에 따른다. 계획이 제출되지 않거나 채택되지 않거나 기한 내에 진행 및 준수가 이루어지지 않을 경우, 상장폐지 절차가 시작될 수 있으며, 항소권은 제1010조 및 Part 12에 따라 주어진다. 이 통지는 회사의 ADS 상장에 즉각적인 영향을 미치지 않으며, cure 기간 동안 다른 NYSE American 요건에 따라 계속 거래될 것이다.

Eason Technology Limited a signalé avoir reçu un avis de non-conformité de NYSE American concernant le maintien des exigences de cotation. L'échange a cité des fonds propres d'actionnaires de 28 millions de RMB (environ 3,8 millions USD) au 31 décembre 2024, et des pertes d'exercice continu et/ou des pertes nettes dans trois des quatre exercices les plus récents.

La société doit soumettre un plan de conformité d'ici le 13 novembre 2025 et rétablir la conformité d'ici le 14 avril 2027, conformément aux procédures de la section 1009. Si un plan n'est pas soumis ou accepté, ou si les progrès et la conformité ne sont pas atteints à la date limite, des procédures de radiation peuvent être engagées, avec droits d'appel en vertu de la section 1010 et de la Partie 12. L'avis n'a pas d'impact immédiat sur la cotation des ADS de la société, qui continuera à être négociée pendant la période de cure sous réserve d'autres exigences NYSE American.

Eason Technology Limited meldete, dass es eine NYSE American-Mitteilung über Nichteinhaltung der fortlaufenden Listing-Standards erhalten hat. Die Börse nannte das Eigenkapital der Aktionäre von RMB 28 Millionen (ca. USD 3,8 Millionen) zum 31. Dezember 2024 und Verluste aus fortlaufenden Operationen und/oder Nettverluste in drei der vier jüngsten Geschäftsjahre.

Das Unternehmen muss bis zum 13. November 2025 einen Compliance-Plan vorlegen und die Einhaltung bis zum 14. April 2027 gemäß den Verfahren der Section 1009 wiederherstellen. Wenn kein Plan vorgelegt oder akzeptiert wird oder wenn Fortschritte und Compliance nicht bis zum Stichtag erreicht werden, können Delisting-Verfahren eingeleitet werden, mit Widerspruchsrechten nach Section 1010 und Teil 12. Die Mitteilung hat keine unmittelbaren Auswirkungen auf die Börsennotierung der ADS des Unternehmens; diese werden während der Cure-Periode weiterhin gehandelt, vorbehaltlich anderer NYSE American-Anforderungen.

Eason Technology Limited أبلغت أنها تلقت إشعاراً من NYSE American بعدم الامتثال لمعايير الاستمرار في القيد. وأشارت البورصة إلى حقوق المساهمين البالغة 28 مليون رنمينبي (حوالي 3.8 ملايين دولار أمريكي) كما في 31 ديسمبر 2024، وخسائر من العمليات المستمرة و/أو خسائر صافية في ثلاثة من أربعة أعوام مالية من الأحدث.

يجب على الشركة تقديم خطة امتثال بحلول 13 نوفمبر 2025، واستعادة الامتثال بحلول 14 أبريل 2027، وفقاً لإجراءات القسم 1009. إذا لم يتم تقديم الخطة أو قبولها، أو لم تتحقق التقدم والامتثال قبل الموعد النهائي، قد تبدأ إجراءات شطب الإدراج، مع حقوق الاستئناف وفق القسم 1010 والجزء 12. لا تؤثر الإشعار بشكل فوري على إدراج الـ ADS الخاصة بالشركة، والتي ستستمر في التداول خلال فترة العلاج وفقاً لمتطلبات NYSE American الأخرى.

Eason Technology Limited 已收到NYSE American关于持续上市标准违规的通知。交易所引用截至2024年12月31日的股东权益为2800万人民币(约380万美元),以及在过去四个财政年度中有三个年度来自持续经营的亏损和/或净亏损。

公司必须在2025年11月13日前提交合规计划,并在2027年4月14日前实现合规,依据第1009条程序执行。如果未提交或未被接受计划,或若在截止日期前未取得进展和合规,可能启动退市程序,并可依据第1010条和第12部分提出上诉。该通知对公司 ADS 的上市没有立即影响,ADS 将在 cure 期内继续交易,但须遵守 NYSE American 的其他要求。

Positive
  • None.
Negative
  • NYSE American deficiency notice citing stockholders’ equity of RMB 28 million (about USD$3.8 million) and multi-year losses, with potential delisting if compliance plan and milestones are not met.

Insights

Listing deficiency raises delisting risk if plan fails.

The exchange flagged Eason Technology for low stockholders’ equity and multi-year losses, triggering Section 1009 procedures. The disclosed equity level is RMB 28 million (about $3.8 million) as of December 31, 2024, alongside losses in three of the last four fiscal years.

Under these rules, the company must submit a plan by November 13, 2025 and regain compliance by April 14, 2027. If the plan is not accepted, or if execution falls short, the exchange can initiate delisting, though the company may appeal.

ADSs remain listed during the cure period, contingent on meeting other NYSE American requirements. Actual outcome will depend on plan acceptance and the company’s ability to meet the compliance milestones outlined by the exchange.

Eason Technology Limited ha ricevuto una notifica NYSE American di non conformità ai requisiti di quotazione continuata. Lo scambio ha citato come patrimonio netto di RMB 28 milioni (circa 3,8 milioni di USD) al 31 dicembre 2024, e perdite dalle operazioni continue e/o perdite nette in tre dei quattro ultimi esercizi fiscali.

La società deve presentare un piano di conformità entro il 13 novembre 2025 e ripristinare la conformità entro il 14 aprile 2027, ai sensi delle procedure della Sezione 1009. Se un piano non viene presentato o accettato, o se i progressi e la conformità non sono raggiunti entro la scadenza, possono avviarsi le procedure di ritiro dalla quotazione, con diritti di ricorso ai sensi della Sezione 1010 e della Parte 12. La notifica non ha alcun impatto immediato sulla quotazione degli ADS dell'azienda, che continueranno a negoziarsi durante il periodo di conformità soggetti ad altri requisiti NYSE American.

Eason Technology Limited informó que recibió una notificación de NYSE American por incumplimiento de los estándares de listado continuado. La bolsa citó un patrimonio de los accionistas de RMB 28 millones (aproximadamente USD 3,8 millones) al 31 de diciembre de 2024, y pérdidas de operaciones continuas y/o pérdidas netas en tres de los cuatro años fiscales más recientes.

La empresa debe presentar un plan de cumplimiento antes del 13 de noviembre de 2025 y restablecer el cumplimiento antes del 14 de abril de 2027, conforme a los procedimientos de la Sección 1009. Si no se presenta o no se acepta un plan, o si no se logran avances y cumplimiento antes de la fecha límite, pueden iniciarse procedimientos de retirada de la cotización, con derechos de apelación bajo la Sección 1010 y la Parte 12. La notificación no tiene un impacto inmediato en la cotización de las ADS de la empresa, que seguirán negociándose durante el periodo de cure, sujeto a otros requisitos de NYSE American.

Eason Technology Limited는 NYSE American의 상장 유지 기준 비준수 통지를 받았다고 발표했다. 거래소는 2024년 12월 31일 기준 주주지분이 2,800만 Renminbi(RMB)이고(약 380만 달러) 그리고 최근 4개 회계연도 중 3개에서 계속영업으로 인한 손실 및/또는 순손실이 발생했다고 밝혔다.

회사는 2025년 11월 13일까지 준수 계획을 제출하고 2027년 4월 14일까지 준수를 회복해야 하며, 이는 제1009조 절차에 따른다. 계획이 제출되지 않거나 채택되지 않거나 기한 내에 진행 및 준수가 이루어지지 않을 경우, 상장폐지 절차가 시작될 수 있으며, 항소권은 제1010조 및 Part 12에 따라 주어진다. 이 통지는 회사의 ADS 상장에 즉각적인 영향을 미치지 않으며, cure 기간 동안 다른 NYSE American 요건에 따라 계속 거래될 것이다.

Eason Technology Limited a signalé avoir reçu un avis de non-conformité de NYSE American concernant le maintien des exigences de cotation. L'échange a cité des fonds propres d'actionnaires de 28 millions de RMB (environ 3,8 millions USD) au 31 décembre 2024, et des pertes d'exercice continu et/ou des pertes nettes dans trois des quatre exercices les plus récents.

La société doit soumettre un plan de conformité d'ici le 13 novembre 2025 et rétablir la conformité d'ici le 14 avril 2027, conformément aux procédures de la section 1009. Si un plan n'est pas soumis ou accepté, ou si les progrès et la conformité ne sont pas atteints à la date limite, des procédures de radiation peuvent être engagées, avec droits d'appel en vertu de la section 1010 et de la Partie 12. L'avis n'a pas d'impact immédiat sur la cotation des ADS de la société, qui continuera à être négociée pendant la période de cure sous réserve d'autres exigences NYSE American.

Eason Technology Limited meldete, dass es eine NYSE American-Mitteilung über Nichteinhaltung der fortlaufenden Listing-Standards erhalten hat. Die Börse nannte das Eigenkapital der Aktionäre von RMB 28 Millionen (ca. USD 3,8 Millionen) zum 31. Dezember 2024 und Verluste aus fortlaufenden Operationen und/oder Nettverluste in drei der vier jüngsten Geschäftsjahre.

Das Unternehmen muss bis zum 13. November 2025 einen Compliance-Plan vorlegen und die Einhaltung bis zum 14. April 2027 gemäß den Verfahren der Section 1009 wiederherstellen. Wenn kein Plan vorgelegt oder akzeptiert wird oder wenn Fortschritte und Compliance nicht bis zum Stichtag erreicht werden, können Delisting-Verfahren eingeleitet werden, mit Widerspruchsrechten nach Section 1010 und Teil 12. Die Mitteilung hat keine unmittelbaren Auswirkungen auf die Börsennotierung der ADS des Unternehmens; diese werden während der Cure-Periode weiterhin gehandelt, vorbehaltlich anderer NYSE American-Anforderungen.

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of October 2025

 

Commission file number: 001-34958

 

EASON TECHNOLOGY LIMITED

 

Room 612, 6/F, KaiYue Comm Building, No. 2C,

Argyle Street, Mongkok Kowloon, Hong Kong,  

People’s Republic of China 

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40- F.

 

Form 20-F ☒     Form 40-F ☐

 

 

 

 

Notice of Failure to Satisfy a Continued Listing Rule

 

On October 14, 2025, Eason Technology Limited (“Eason Technology” or the “Company”) received a notice from NYSE Regulation indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC (“NYSE American” or the “Exchange”). The Company is below compliance with Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) since it reported stockholders’ equity of RMB 28 million (approximately USD$3.8 million based on an exchange rate of RMB 7.2993 to US$1.00) as of December 31, 2024, and losses from continuing operations and/or net losses in three of its four most recent fiscal years ended December 31, 2024 (the “Deficiency”). The Company is also not currently eligible for any exemption in Section 1003(a) of the Company Guide from the stockholders’ equity requirements.

 

The Company is now subject to the procedures and requirements set forth in Section 1009 of the Company Guide. In connection with its Deficiency, the Company must submit a plan by November 13, 2025 (“Plan Due Date”), advising of actions it has taken or will take to regain compliance with the continued listing standards by April 14, 2027 (“Compliance Deadline”).

 

If the Company does not submit a compliance plan or if the plan is not accepted, delisting proceedings will commence. Furthermore, if the plan is accepted but the Company is not in compliance with the continued listing standards by the Compliance Deadline, or if the Company does not make progress consistent with the plan during the plan period, Exchange staff will initiate delisting proceedings as appropriate. The Company may appeal a staff delisting determination in accordance with Section 1010 and Part 12 of the Company Guide.

 

This delinquency notice has no immediate impact on the listing of the Company’s ADSs, which will continue to be listed and traded on the NYSE American during the cure period subject to continued compliance with the other listing requirements of the NYSE American.

 

On October 20, 2025, the Company issued a press release announcing receipt of the delinquency notice. A copy of the press release is furnished hereto as Exhibit 99.1 and is incorporated herein by reference.

 

 

2

 

 

Exhibit Index

 

Exhibit No.

 

Description

99.1

 

Press Release

 

 

3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Eason Technology Limited

 

 

 

 

 

Date: October 20, 2025

By:

/s/ Longwen (Stanley) He

 

 

Name:

Longwen (Stanley) He

 

 

Title:

Chief Executive Officer

 

 

 

4

 

FAQ

What did Eason Technology (DXF) disclose in its 6-K?

It received a NYSE American notice of noncompliance due to stockholders’ equity of RMB 28 million (about USD$3.8 million) and losses in three of the last four years.

Which NYSE American standard did Eason Technology (DXF) fail to meet?

Section 1003(a)(ii) of the NYSE American Company Guide related to stockholders’ equity, alongside a history of losses.

What are the key deadlines for Eason Technology (DXF) to regain compliance?

Submit a plan by November 13, 2025, and achieve compliance by April 14, 2027.

Will Eason Technology’s (DXF) ADSs continue trading?

Yes. The ADSs will continue to be listed and traded during the cure period, subject to other NYSE American requirements.

What happens if Eason Technology (DXF) misses the plan or compliance milestones?

If no plan is submitted or accepted, or if compliance is not achieved by the deadline, delisting proceedings may begin, with appeal rights available.

What equity level did Eason Technology (DXF) report?

Stockholders’ equity was RMB 28 million (approximately USD$3.8 million) as of December 31, 2024.
Eason Technology

NYSE:DXF

DXF Rankings

DXF Latest News

DXF Latest SEC Filings

DXF Stock Data

4.33M
1.38M
17.43%
12.25%
Credit Services
Financial Services
Link
China
Wuhan